JW Therapeutics Announces Initiation of Clinical Study of JW

/PRNewswire/ -- JW Therapeutics (HKEX: 2126), an independent and innovative biotechnology company focusing on developing, manufacturing and commercializing...

Related Keywords

Hong Kong , Jian Zhou , Zhejiang , China , Taiwan , Yang Xie , Shanghai , Macao , Macau General , Macau , Chinese , Qiang Gao , Jia Fan , Association Of Southeast Asian Nations , Southeast Asian , Zheng Gang Ren , Chimeric Antigen , Cell Therapy , Advanced Hepatocellular Carcinoma , Clin Cancer Res , Jw Therapeutics ,